Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Baldi

Showing results (171-180 of 185) with videos related to

Pageof 19
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 15, 2023
A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl)Emanuela Palmerini, Marco Gambarotti, Antoine Italiano, et al.
ESMO Open|January 21, 2026
International multicenter retrospective study on pleomorphic rhabdomyosarcoma (P-RMS), a PUSH platform study: outcome of primary localized diseaseC Giani, G G Baldi, S Ljevar, et al.
Cancer|September 20, 2019
Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma NetworkAnna Maria Frezza, Tarek Assi, Salvatore Lo Vullo, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2026
Pleomorphic rhabdomyosarcoma, outcomes of patients with advanced disease treated with systemic agents: Retrospective study from the global pushing ultra-rare sarcomas towards hope (PUSH) consortiumGiacomo G Baldi, Claudia Giani, Silva Ljevar, et al.
ESMO Open|September 12, 2024
Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working GroupC Giani, R A Denu, S Ljevar, et al.
The American Journal of Surgical Pathology|October 28, 2024
International Multicenter Retrospective Study From the Ultra-rare Sarcoma Working Group on Low-grade Fibromyxoid Sarcoma, Sclerosing Epithelioid Fibrosarcoma, and Hybrid Forms: Outcome of Primary Localized DiseaseClaudia Giani, Abdulazeez Salawu, Silva Ljevar, et al.
JAMA Oncology|February 26, 2026
Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 MutationsAndrea Napolitano, Heikki Joensuu, Sara Rothschild, et al.
Plos One|August 12, 2024
The observational EURACAN prospective clinical registry dedicated to epithelioid hemangioendothelioma: The protocol of an international and collaborative effort on an ultra-rare entityAnna Maria Frezza, Hugh Leonard, Ninna Aggerholm-Pedersen, et al.
Cancer Treatment Reviews|August 28, 2022
Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatmentsSilvia Stacchiotti, Anna Maria Frezza, George D Demetri, et al.
Journal of Preventive Medicine and Hygiene|May 18, 2007
Quality in emergency departments: a study on 3,285,440 admissionsM Sartini, P Cremonesi, R Tamagno, et al.
Pageof 19

Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
European Journal of Cancer (Oxford, England : 1990)|February 15, 2023
A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl)Emanuela Palmerini, Marco Gambarotti, Antoine Italiano, et al.
ESMO Open|January 21, 2026
International multicenter retrospective study on pleomorphic rhabdomyosarcoma (P-RMS), a PUSH platform study: outcome of primary localized diseaseC Giani, G G Baldi, S Ljevar, et al.
Cancer|September 20, 2019
Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma NetworkAnna Maria Frezza, Tarek Assi, Salvatore Lo Vullo, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2026
Pleomorphic rhabdomyosarcoma, outcomes of patients with advanced disease treated with systemic agents: Retrospective study from the global pushing ultra-rare sarcomas towards hope (PUSH) consortiumGiacomo G Baldi, Claudia Giani, Silva Ljevar, et al.
ESMO Open|September 12, 2024
Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working GroupC Giani, R A Denu, S Ljevar, et al.
The American Journal of Surgical Pathology|October 28, 2024
International Multicenter Retrospective Study From the Ultra-rare Sarcoma Working Group on Low-grade Fibromyxoid Sarcoma, Sclerosing Epithelioid Fibrosarcoma, and Hybrid Forms: Outcome of Primary Localized DiseaseClaudia Giani, Abdulazeez Salawu, Silva Ljevar, et al.
JAMA Oncology|February 26, 2026
Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 MutationsAndrea Napolitano, Heikki Joensuu, Sara Rothschild, et al.
Plos One|August 12, 2024
The observational EURACAN prospective clinical registry dedicated to epithelioid hemangioendothelioma: The protocol of an international and collaborative effort on an ultra-rare entityAnna Maria Frezza, Hugh Leonard, Ninna Aggerholm-Pedersen, et al.
Cancer Treatment Reviews|August 28, 2022
Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatmentsSilvia Stacchiotti, Anna Maria Frezza, George D Demetri, et al.
Journal of Preventive Medicine and Hygiene|May 18, 2007
Quality in emergency departments: a study on 3,285,440 admissionsM Sartini, P Cremonesi, R Tamagno, et al.
Pageof 19